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In patients with Alzheimer’s disease or Down’s syn-
drome, the cerebellar cortex exhibits protein deposits in
neurofibrillary tangles and neuritic plaques. Recently,
the deposits have been shown to contain protein frag-
ments of ubiquitin-B and amyloid precursor protein
(APP) with an aberrant carboxyl terminus resulting
from frameshift mutations (dinucleotide deletions; DGU
or DGA) in or adjacent to GAGAG motifs in their mRNAs,
a process referred to as molecular misreading. We have
now used a bacterial expression system with the green
fluorescent protein as a reporter to screen gene tran-
scripts from aged controls, Alzheimer’s disease, and
Down’s syndrome for molecular misreading. Novel
frameshift mutations at a number of locations in the
transcripts of the ubiquitin-B and APP genes were dis-
covered (DGA, DG, DGU, DGG, DCA, DAU, DA, DAA, DC,
DU, and insertion of an A). Interestingly, most mutations
were in close proximity of short simple repeats (GAGAG,
GGUGGU, GAGACACACA, UCAUCAUCA, CAAACAAA, and
GAAGAAGAA), demonstrating that the GAGAG motif does
not constitute the only hot spot for transcriptional errors.
Unlike the previously detected aberrant APP fragments,
some of the novel ones have the potential to generate the
neurotoxic peptide b-amyloid. We conclude that during ag-
ing molecular misreading is a widespread phenomenon.
Alzheimer’s disease (AD)1 is a neurodegenerative disorder of
the brain and accounts for the most frequent form of dementia
at higher age. The disease is characterized by the presence of
neurofibrillary tangles, neuropil threads, and neuritic plaques
in the brain. A major constituent of the plaques is b-amyloid, a
neurotoxic peptide generated by processing of the type I trans-
membrane b-amyloid precursor protein APP (1). Two different
types of AD can be discriminated, namely the early-onset (fa-
milial) and the late-onset (sporadic) forms. The sporadic form
accounts for more than 60% of all AD cases, but the cause of the
development of these cases is unknown. A recent study pro-
vided a new view on the mechanism that may underly aging
and that in particular may contribute to the development of the
sporadic forms of AD and Down’s syndrome (DS; see Refs. 2 and
3). The new view is referred to as molecular misreading and is
based on the finding of a novel type of dinucleotide deletion in
or adjacent to a GAGAG motif in the mRNA transcripts of two
neuronal genes encoding APP and the cytoplasmic garbage
protein ubiquitin-B (Ubi-B) (2). These mutations were found at
the RNA and not the DNA level and resulted in frameshifts and
proteins with an aberrant carboxyl terminus (2–4). The same
type of frameshift mutations may underlie other neuropathol-
ogies and age-related diseases.
To examine how widespread the phenomenon of molecular
misreading is and whether hot spots other than GAGAG may
occur, we have developed a bacterial expression system with
the green fluorescent protein (GFP) as a reporter and success-
fully used this system for the screening of frameshift mutations
in mRNAs even when the mutational rate is low. We discovered
novel frameshift mutations at different sites in Ubi-B and APP
gene transcripts isolated from cortical regions of aged
individuals.
EXPERIMENTAL PROCEDURES
Isolation of RNA—Using a standard Trizol procedure (Life Technol-
ogies, Inc.), total RNA was extracted from cortical regions of aged
individuals that had suffered from AD or DS (patients 92-080 (DS, 58,
C) and 93-048 (DS, 67, C) were obtained from the Netherlands Brain
Bank, Amsterdam, The Netherlands; patients 92-50-529 (control, 96,
C), 92-50-692 (control with plaques, 85, C), 94-52-312 (control, 85, C),
95-50-665 (control, 84, C), 88-50-322 (AD, 85, C), 88-52-120 (AD, 83, C),
92-51-371 (AD, 81, C), 95-51-242 (AD, 79, Z), and 95-51-014 (AD, 81, C)
were obtained from the Department of Pathology, University of Nijme-
gen, The Netherlands).
RT-PCR—Single stranded cDNA was synthesized by using 2 mg of
total RNA, randomly primed with hexamers and reverse transcribed
with RT Superscript II (Life Technologies, Inc.). The PCR was per-
formed with PWO DNA polymerase (proofreading activity; Roche Mo-
lecular Biochemicals). Initially, we experienced a technical problem in
that a substantial percentage (;1%) of the synthesized primers was
found to contain a deletion or an insertion of a nucleotide. Therefore,
primers (Biolegio, Malden, The Netherlands) were purified by SDS-
PAGE to diminish background signals caused by the mistakes made
during primer synthesis. The primers used for Ubi-B mRNA analysis
were 59-ggggggggaagcttccgctatcaggtcaaaatg-39 as forward and 59-
gggggtctagatcttcacgaagatctgcat-39 as reverse primer (255-bp PCR prod-
uct). For APP mRNA analysis, the following primer sets were used:
APP-ex9 with 59-gggggaagctttgcccatttccagaaagcc-39 as forward and 59-
gggggtctagacggcggtcattgagcatggc-39 as reverse primer (242-bp product);
APP-BA with 59-ggggaagctttgggttgacaaatatcaagagc-39 as forward and
59-ggggtctagattctgcatctgctcaaagaac-39 as reverse primer (APP-BA1;
341-bp product) or 59-ggggtctagattttcgtagccgttctgctgc-39 as reverse
primer (APP-BA2; 312-bp product); APP-CT with 59-gggggaagcttgaa-
gaagaaacagtacaca-39 as forward and 59-ggggtctagattctgcatctgctcaaa-
gaac-39 as reverse primer (APP-CT1; 141 bp product) or 59-ggggtcta-
gattttcgtagccgttctgctgc-39 as reverse primer (APP-CT2; 112 bp product).
Screening Strategy—PCR products were gel-purified, digested with
HindIII and XbaI, and subcloned into the bacterial vector pGFPuv
(6079–1; CLONTECH; GenBankTM accession number U62636; see Fig.
1). DNA was isolated from selected clones (Flexiprep kit, Amersham
Pharmacia Biotech), and insert sizes were determined. During the
development of this method we experienced a background signal caused
by internal initiation of translation at the first AUG of the GFP coding
region. To prevent this background signal, this AUG was removed via
PCR with 59 primer ggtcgactctagaaaaaagtaaaggagaagaacttttcactgg and
39 primer ctcagttggaattcattatttgtagagctcatgcatgccatg. The mutated con-
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struct is referred to as pGFP*uv and was used for the cloning of the
PCR products to identify the frameshift mutations. DNA sequence
analysis was performed according to the manufacturer’s protocol (ABI
Prism 310; PerkinElmer Life Sciences). The screening strategy provides
different ways to detect frameshift mutations. The Ubi-B primers were
designed in such a way that clones containing a wild type insert would
show no fluorescence, whereas clones containing an insert with a dinu-
cleotide deletion would generate weak fluorescence. By changing the 39
primer one could also search for deletions of one nucleotide. For the
detection of mutations in APP gene transcripts, the primers were de-
signed in such a way that the wild type APP is in frame with GFP,
whereas a frameshift would lead to nonfluorescent bacteria. However,
one of the wild type APP PCR fragments (generated with primers
APP-BA1 and APP-BA2) was found to result in a nonfluorescent GFP
fusion protein because of the size of the insert. Surprisingly, in this case
a number of fluorescent bacteria were still detected, and sequencing of
these clones revealed the presence of APP frameshift mutations. These
frameshifts caused an early termination of translation, and it is likely
that reinitiation of translation occurred to generate a fluorescent GFP
fusion protein.
RESULTS AND DISCUSSION
Age-related frameshift mutations in gene transcripts have
been shown to occur in Brattleboro rats (5) and in patients who
had suffered from AD or DS (2). These frameshift mutations
are generated at the RNA and not the DNA level, and this
process has been referred to as molecular misreading (6). The
FIG. 1. Schematic representation of
wild type APP and APP fragments re-
sulting from frameshift mutations.
APP11, APP fragment resulting from a
DGU dinucleotide frameshift mutation
previously identified and lacking the Ab
region (2). APP-CT12, APP fragment con-
taining the Ab region and due to a frame-
shift mutation in the cytoplasmic tail of
APP resulting in a protein with a tail
lacking one (in the case of DC) or both
(DG) localization/targeting signals that
are boxed in wild type APP (wtAPP); APP-
CT12 has the potential to generate Ab.
SP, signal peptide; TM, transmembrane
region.2, b-amyloid (Ab); uand u??,
aberrant C-terminal regions resulting
from frameshift mutations.
TABLE I
Frameshift mutations detected in human brain RNA of aged individuals (controls (C) and patients that had suffered from AD or DS)
Nucleotide numbering corresponds to accession number X04803 (Ubi-B; see Ref. 15) and to accession number Y00264 (APP; see Ref. 16). Repeats
are underlined, and the mutations are in bold.
* Mutations that have previously been reported by Van Leeuwen et al. (2).
Y Indicates an aged control with plaques.
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frameshifts were detected with an immunoscreening procedure
implying the need for a specific antibody for each mutation to
be investigated. To circumvent the necessity for the generation
of an antibody for the detection of any new mutation, we de-
veloped a bacterial expression cloning strategy involving the
use of GFP as a reporter protein to screen PCR fragments up to
300 nucleotides in length for the presence of frameshift muta-
tions (see “Experimental Procedures”). To examine the sensi-
tivity of the method and to show that the mutations are not
generated as a result of a PCR artifact, constructs containing
either wild type Ubi-B or Ubi-B with the dinucleotide deletion
previously described (DGU; Ubi-B11; see Ref. 2) were used in
different ratios ranging from 1:1 to 1:10000 (wild type:DGU).
Even at a ratio of 1:10000 the (weakly) fluorescent clones
containing the frameshift mutation could still be detected at
the expected frequency. Subsequently, the validity of the pro-
cedure was checked by searching for a frameshift that is known
to occur in Ubi-B gene transcripts isolated from human DS
brain tissue (2). A GU deletion following a GAGAG motif in the
Ubi-B transcript identical to the one reported earlier (2) was
indeed found (Table I). Because the PCR primers corresponded
to regions located in separate exons of the Ubi-B gene, the size
of the PCR fragment (255 bp) revealed that the mutations were
detected at the RNA and not the DNA level. Interestingly, in
addition to the DGU, we discovered several novel mutations
(DGA, DG, DGG, and insertion of an A) (Table I). These novel
mutations were also located adjacent to the GAGAG motif
described earlier, except for the insertion of an A, which oc-
curred adjacent to a GGUGGU motif. This latter observation
indicates the importance of simple repeats for the process of
molecular misreading.
Another transcript previously shown to contain dinucleotide de-
letions at a GAGAG motif is produced by the APP gene (2). In exons
9 and 10 of the APP gene, three GAGAG motifs are clustered. When
applying our strategy on RNA derived from aged individuals, we
were again able to confirm the previously observed GA deletion in
the second GAGAG motif in exon 9 (Table I). Furthermore, we
detected a CA deletion in exon 11 that, remarkably, occurred in a
GAGACACACA motif, again pointing to the involvement of simple
repeats in molecular misreading. Molecular misreading in neither
exon 9 nor exon 11 of the APP gene can, however, by itself lead to
an increase in the production of Ab, because the APP fragments
generated by these frameshift mutations do not contain the Ab
peptide region (encoded by exons 16 and 17 of the APP gene). In
contrast, the occurrence of a frameshift mutation in a region of the
mRNA corresponding to the C-terminal cytoplasmic region of APP
would lead to an aberrant protein with the potential to give rise to
Ab (Fig. 1). We therefore searched for mutations in the mRNA
region encoding the C-terminal part of APP, and this analysis
revealed a number of novel frameshift mutations, namely DA and
DAA (both in UCAUCAUCAAAAAUUGG), DA (UUCAAA-
CAAAGGUGCAAUCAUUC), DG (UUGGACUCAUGGUGGGCG-
GUUGUU; UUCAAACAAAGGUGCAAUCAUUC; GAAGAAGA-
AACAGUACACA), DU (UGAUCGUCAUCACACCU), and DC
(CTGTCACCCCAGAGGAG) (Table I). Some of these mutations
occurred in close proximity of short simple repeats (UCAUCAUCA,
CAAACAAA, and GAAGAAGAA). The mutations were not only
detected in mRNAs derived from patients who had suffered from
AD or DS but also in temporal cortex mRNAs of aged controls.
Interestingly, the control that showed the highest mutation fre-
quency exhibited plaques in the brain.
The aberrant proteins resulting from molecular misreading
might affect cell physiology. For instance, the previously pub-
lished Ubi-B11 protein, lacking Glycine residue 76 that is es-
sential for recognition of the target protein (7), is no longer able
to ubiquitinilate proteins in vitro.2 The above-mentioned novel
frameshift mutations in the Ubi-B gene transcripts probably
also result in ubiquitin molecules unable to function properly.
Concerning the APP protein one should consider its cytoplas-
mic tail that contains two sorting signals (YTSI and YENPTY),
characterized as internalization and endosomal/lysosomal tar-
geting signals, and necessary for intracellular trafficking of
APP. Deleting or mutating these signals indeed affects APP
routing (8–13). The frameshift deletions DG at nucleotide 2103
and DC at nucleotide 2153, in the part of the APP transcript
encoding the cytoplasmic region, result in proteins with an
aberrant and elongated cytoplasmic tail lacking one or both of
the targeting signals of APP (Fig. 1). Because an affected APP
routing may lead to an increased production of Ab (14), the
novel APP proteins with the aberrant tails may give rise to this
neurotoxic peptide.
Although the frameshift mutations were found at a relatively
low rate (1:950 to 1:8600 transcripts; see Table I), at the single
cell level the frequency may be considerably higher. Immuno-
cytochemical analysis has revealed that only a small percent-
age of cells contain the aberrant frameshift proteins, indicating
that molecular misreading is indeed restricted to a minority of
neuronal cells (2). In an affected cell, the percentage of mutated
transcripts may well be relatively high, which could signifi-
cantly contribute to the malfunctioning of such a cell, possibly
eventually even promoting its degeneration. We conclude that
during aging molecular misreading is a widespread event oc-
curring at a variety of short simple repeats.
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